NO943239L - Pyrido[1,2,3-d,eÅ[1,3,4Åbenzoksadiazinderivater - Google Patents
Pyrido[1,2,3-d,eÅ[1,3,4ÅbenzoksadiazinderivaterInfo
- Publication number
- NO943239L NO943239L NO943239A NO943239A NO943239L NO 943239 L NO943239 L NO 943239L NO 943239 A NO943239 A NO 943239A NO 943239 A NO943239 A NO 943239A NO 943239 L NO943239 L NO 943239L
- Authority
- NO
- Norway
- Prior art keywords
- stands
- hydrogen
- methyl
- ethyl
- eaa
- Prior art date
Links
- 229910052739 hydrogen Inorganic materials 0.000 abstract 10
- 239000001257 hydrogen Substances 0.000 abstract 10
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 7
- 150000002431 hydrogen Chemical class 0.000 abstract 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 2
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 1
- LEOWVNIWIPWHBX-UHFFFAOYSA-N 3h-4,1,2-benzoxadiazine Chemical class C1=CC=C2N=NCOC2=C1 LEOWVNIWIPWHBX-UHFFFAOYSA-N 0.000 abstract 1
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4329600A DE4329600A1 (de) | 1993-09-02 | 1993-09-02 | Pyrido [1,2,3-d,e] [1,3,4] benzoxadiazinderivate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO943239D0 NO943239D0 (no) | 1994-09-01 |
| NO943239L true NO943239L (no) | 1995-03-03 |
Family
ID=6496640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO943239A NO943239L (no) | 1993-09-02 | 1994-09-01 | Pyrido[1,2,3-d,eÅ[1,3,4Åbenzoksadiazinderivater |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US5508278A (en, 2012) |
| EP (1) | EP0647644B1 (en, 2012) |
| JP (1) | JPH0782272A (en, 2012) |
| KR (1) | KR100342034B1 (en, 2012) |
| CN (1) | CN1041731C (en, 2012) |
| AT (1) | ATE159944T1 (en, 2012) |
| AU (1) | AU687833B2 (en, 2012) |
| CA (1) | CA2131103C (en, 2012) |
| CZ (1) | CZ211394A3 (en, 2012) |
| DE (2) | DE4329600A1 (en, 2012) |
| DK (1) | DK0647644T3 (en, 2012) |
| EG (1) | EG20425A (en, 2012) |
| ES (1) | ES2108348T3 (en, 2012) |
| FI (1) | FI943999A7 (en, 2012) |
| GR (1) | GR3025740T3 (en, 2012) |
| HR (1) | HRP940470B1 (en, 2012) |
| HU (1) | HUT71098A (en, 2012) |
| IL (1) | IL110828A (en, 2012) |
| JO (1) | JO1799B1 (en, 2012) |
| MY (1) | MY131768A (en, 2012) |
| NO (1) | NO943239L (en, 2012) |
| NZ (1) | NZ264334A (en, 2012) |
| PH (1) | PH31003A (en, 2012) |
| PL (1) | PL177249B1 (en, 2012) |
| RU (1) | RU2131430C1 (en, 2012) |
| SI (1) | SI0647644T1 (en, 2012) |
| SV (1) | SV1994000041A (en, 2012) |
| TW (1) | TW304196B (en, 2012) |
| UY (1) | UY23825A1 (en, 2012) |
| ZA (1) | ZA946700B (en, 2012) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4416622A1 (de) * | 1994-05-11 | 1995-11-16 | Bayer Ag | 8-Amino-10-(azabicycloalkyl)-pyrido[1,2,3-d.e] [1,3,4]benzoxa-diazinderivate |
| DE4427530A1 (de) * | 1994-08-04 | 1996-02-08 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäure-Derivate |
| DE4435479A1 (de) | 1994-10-04 | 1996-04-11 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäure-Derivate |
| KR100411620B1 (ko) * | 1995-12-29 | 2004-03-18 | 고려화학 주식회사 | Pvc프레임용불소도료조성물 |
| DE19652239A1 (de) * | 1996-12-16 | 1998-06-18 | Bayer Ag | Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen |
| FR2928150A1 (fr) * | 2008-02-29 | 2009-09-04 | Vetoquinol Sa Sa | Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens |
| EP2145891A1 (en) * | 2008-07-09 | 2010-01-20 | Vetoquinol S.A. | 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0635458B2 (ja) * | 1985-02-15 | 1994-05-11 | 大日本製薬株式会社 | ピリドンカルボン酸誘導体、そのエステルおよびその塩 |
| EP0259804B1 (de) * | 1986-09-12 | 1993-11-18 | F. Hoffmann-La Roche Ag | Pyrido [3,2,1-ij]-1,3,4-benzoxadiazinderivate, Verfahren zu deren Herstellung, entsprechende pharmazeutische Präparate und im Verfahren verwendbare Zwischenprodukte |
| US4864023A (en) * | 1986-09-12 | 1989-09-05 | Hoffmann-La Roche Inc. | Pyrido(3,2,1-IJ)-1,3,4-benzoxadiazine derivatives |
| US5563138A (en) * | 1987-04-16 | 1996-10-08 | Otsuka Pharmaceutical Company, Limited | Benzoheterocyclic compounds |
| JP2844079B2 (ja) * | 1988-05-23 | 1999-01-06 | 塩野義製薬株式会社 | ピリドンカルボン酸系抗菌剤 |
| DE3906365A1 (de) * | 1988-07-15 | 1990-01-18 | Bayer Ag | 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe |
| DE3910663A1 (de) * | 1989-04-03 | 1990-10-04 | Bayer Ag | 5-alkylchinoloncarbonsaeuren |
| GB9010941D0 (en) * | 1990-05-16 | 1990-07-04 | Erba Carlo Spa | Delta 2-cephem sulphones |
| DE4032560A1 (de) * | 1990-10-13 | 1992-04-16 | Bayer Ag | 7-(2,7-diazabicyclo(3.3.0)octyl)-3-chinolon- und -naphtyridoncarbonsaeure-derivate |
| WO1992012146A1 (fr) * | 1990-12-27 | 1992-07-23 | Banyu Pharmaceutical Co., Ltd. | Derive d'acide pyridonecarboxylique |
| DE4120646A1 (de) * | 1991-06-22 | 1992-12-24 | Bayer Ag | 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate |
| TW209865B (en, 2012) * | 1992-01-10 | 1993-07-21 | Bayer Ag | |
| NO304832B1 (no) * | 1992-05-27 | 1999-02-22 | Ube Industries | Aminokinolonderivater samt middel mot HIV |
| DK0680482T3 (da) * | 1993-01-23 | 1997-05-05 | Pfizer | Fremgangsmåde til fremstilling af en tricyclisk forbindelse |
-
1993
- 1993-09-02 DE DE4329600A patent/DE4329600A1/de not_active Withdrawn
-
1994
- 1994-08-18 HR HRP4329600.9A patent/HRP940470B1/xx not_active IP Right Cessation
- 1994-08-18 TW TW083107566A patent/TW304196B/zh active
- 1994-08-22 ES ES94113044T patent/ES2108348T3/es not_active Expired - Lifetime
- 1994-08-22 EP EP94113044A patent/EP0647644B1/de not_active Expired - Lifetime
- 1994-08-22 DE DE59404525T patent/DE59404525D1/de not_active Expired - Fee Related
- 1994-08-22 DK DK94113044T patent/DK0647644T3/da active
- 1994-08-22 AT AT94113044T patent/ATE159944T1/de not_active IP Right Cessation
- 1994-08-22 SI SI9430115T patent/SI0647644T1/xx unknown
- 1994-08-24 JO JO19941799A patent/JO1799B1/en active
- 1994-08-25 AU AU71485/94A patent/AU687833B2/en not_active Ceased
- 1994-08-26 US US08/296,944 patent/US5508278A/en not_active Expired - Fee Related
- 1994-08-29 EG EG53194A patent/EG20425A/xx active
- 1994-08-29 JP JP6226093A patent/JPH0782272A/ja active Pending
- 1994-08-29 KR KR1019940021421A patent/KR100342034B1/ko not_active Expired - Fee Related
- 1994-08-30 CA CA002131103A patent/CA2131103C/en not_active Expired - Fee Related
- 1994-08-30 NZ NZ264334A patent/NZ264334A/en unknown
- 1994-08-31 FI FI943999A patent/FI943999A7/fi unknown
- 1994-08-31 IL IL110828A patent/IL110828A/xx not_active IP Right Cessation
- 1994-09-01 CZ CZ942113A patent/CZ211394A3/cs unknown
- 1994-09-01 NO NO943239A patent/NO943239L/no unknown
- 1994-09-01 PH PH48892A patent/PH31003A/en unknown
- 1994-09-01 RU RU94031745A patent/RU2131430C1/ru active
- 1994-09-01 ZA ZA946700A patent/ZA946700B/xx unknown
- 1994-09-01 HU HU9402523A patent/HUT71098A/hu unknown
- 1994-09-01 SV SV1994000041A patent/SV1994000041A/es unknown
- 1994-09-02 CN CN94115644A patent/CN1041731C/zh not_active Expired - Fee Related
- 1994-09-02 UY UY23825A patent/UY23825A1/es not_active IP Right Cessation
- 1994-09-02 PL PL94304877A patent/PL177249B1/pl unknown
- 1994-09-02 MY MYPI94002293A patent/MY131768A/en unknown
-
1997
- 1997-12-23 GR GR970403390T patent/GR3025740T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9700308A (es) | Derivados heterobiciclicos. | |
| EA199700209A1 (ru) | ПРОИЗВОДНЫЕ ИМИДАЗО[1,2-a]ПИРИДИНА | |
| NO20060972L (no) | Pyridylderivater og deres anvendelse som terapeutiske midler | |
| HUP0001269A2 (hu) | 2-Oxo-1-azetidin-szulfonsav-származékok és ezeket tartalmazó kombinált gyógyszerkészítmények | |
| MY131501A (en) | Process for the prepration of clavulanic acid | |
| DK0632036T3 (da) | Amidderivater med antipypercholesteræmisk aktivitet, deres fremstilling og deres terapeutiske anvendelser | |
| DK178488A (da) | Amino-5,6,7,8-tetrahydronaphtho(2,3-b)furanderivater, fremgangsmaader til deres fremstilling og farmaceutiske midler indeholdende dem | |
| NO943239L (no) | Pyrido[1,2,3-d,eÅ[1,3,4Åbenzoksadiazinderivater | |
| TW360652B (en) | Acryloyl substituted disstamycin derivatives, process for preparing them, and pharmaceutical composition comprising them | |
| DK300890D0 (da) | Kondenserede pyrazol-3-oxo-propannitrilderivater og fremgangsmaade til fremstilling deraf | |
| FI910303A0 (fi) | Derivat av tiazolidin med blodtrycksnedsaenkande effekt och terapeutisk anvaendning av dessa. | |
| FI884088A0 (fi) | Foerfarande foer framstaellning av 17-substituerade androsta-1,4-dien-3-onderivat. | |
| DK213286A (da) | 2-pyrrolidonderivater, fremgangsmaader til deres fremstilling, samt deres anvendelse i farmaceutiske midler | |
| AU6786290A (en) | Therapeutic application of fluoroquinolone derivatives for pneumocystosis | |
| TW333532B (en) | Benzopyrans | |
| NO951811L (no) | Kinolin- og benzimidazolderivater, deres fremstilling og anvendelse | |
| NO944577L (no) | Hemming av effekten av amyloidogene proteiner | |
| ATE143658T1 (de) | Pyrrolidin-derivate | |
| NO970079L (no) | Pyrido£3,2,1-i,j|£3,1|benzoksazinderivater | |
| BG103045A (en) | Beta, beta-disubstituted derivatives of 9-desoxo-9a-n-ethenyl-9a-aza-9a-homoerythromycin a | |
| DK0582506T3 (da) | Tetrahydronaphthalenderivater, fremgangsmåde til fremstilling deraf og terapeutisk anvendelse af disse | |
| GR3002560T3 (en) | 2-selenomethyl-1, 4-dihydropyridines, a process for the preparation thereof and pharmaceutical compositions containing them | |
| DK0728002T3 (da) | Anvendelse af 2-aminopurinderivater til behandling og forebyggelse af humant herpesvirus 7-infektioner | |
| BR0007729A (pt) | Composto, composição farmacêutica, e, métodos decontrole de infecções bacterianas em umhospedeiro em necessidade de tal terapia, e depreparo de um composto | |
| DK0790237T3 (da) | Bicyclolactamforbindelser, deres anvendelse og mellemprodukter til deres fremstilling |